CN106974922B - 2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 - Google Patents
2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 Download PDFInfo
- Publication number
- CN106974922B CN106974922B CN201610028068.XA CN201610028068A CN106974922B CN 106974922 B CN106974922 B CN 106974922B CN 201610028068 A CN201610028068 A CN 201610028068A CN 106974922 B CN106974922 B CN 106974922B
- Authority
- CN
- China
- Prior art keywords
- coumarate
- cis
- preparation
- cardiospermin
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 18
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 229940079593 drug Drugs 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 241000545405 Tripterygium Species 0.000 abstract description 7
- 229930182470 glycoside Natural products 0.000 abstract description 7
- 150000002338 glycosides Chemical class 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 7
- 210000002966 serum Anatomy 0.000 abstract description 6
- 241000160765 Erebia ligea Species 0.000 abstract description 2
- 208000009386 Experimental Arthritis Diseases 0.000 abstract description 2
- 241001254119 Sorbaria sorbifolia Species 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 3
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 2
- 210000000548 hind-foot Anatomy 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 238000001026 1H--1H correlation spectroscopy Methods 0.000 description 1
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 239000002988 disease modifying antirheumatic drug Substances 0.000 description 1
- 238000002072 distortionless enhancement with polarization transfer spectrum Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610028068.XA CN106974922B (zh) | 2016-01-15 | 2016-01-15 | 2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610028068.XA CN106974922B (zh) | 2016-01-15 | 2016-01-15 | 2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106974922A CN106974922A (zh) | 2017-07-25 |
CN106974922B true CN106974922B (zh) | 2020-12-01 |
Family
ID=59340296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610028068.XA Active CN106974922B (zh) | 2016-01-15 | 2016-01-15 | 2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106974922B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080160059A1 (en) * | 2006-11-08 | 2008-07-03 | Quimica Agronomica De Mexico | Antibiotic/antimycotic preparation and use in plants |
CN101773577A (zh) * | 2010-01-29 | 2010-07-14 | 刘志民 | 用于治疗风湿、关节炎、老年性退行性关节病的关东茶浴包 |
KR20110074194A (ko) * | 2009-12-24 | 2011-06-30 | 주식회사 코스메카코리아 | 쉬땅나무 추출물을 포함하는 피부미백용 화장료 조성물 |
CN104547494A (zh) * | 2015-02-09 | 2015-04-29 | 王秋霞 | 治疗甲亢的中药组合物药酒及制备工艺 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301288B (zh) * | 2013-06-12 | 2014-08-27 | 邬存娟 | 一种治疗痛风性关节炎的中药组合物 |
-
2016
- 2016-01-15 CN CN201610028068.XA patent/CN106974922B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080160059A1 (en) * | 2006-11-08 | 2008-07-03 | Quimica Agronomica De Mexico | Antibiotic/antimycotic preparation and use in plants |
KR20110074194A (ko) * | 2009-12-24 | 2011-06-30 | 주식회사 코스메카코리아 | 쉬땅나무 추출물을 포함하는 피부미백용 화장료 조성물 |
CN101773577A (zh) * | 2010-01-29 | 2010-07-14 | 刘志民 | 用于治疗风湿、关节炎、老年性退行性关节病的关东茶浴包 |
CN104547494A (zh) * | 2015-02-09 | 2015-04-29 | 王秋霞 | 治疗甲亢的中药组合物药酒及制备工艺 |
Non-Patent Citations (3)
Title |
---|
Leucine-derived cyanoglucosides from the aerial parts of Sorbaria sorbifolia (L.) A. Braun;Gui-Wu Qu et al.;《Fitoterapia》;20160406;第111卷;第102-108页 * |
珍珠梅中γ-羟基腈苷Sutherlandin-5-cis-p-coumarate的抗炎、镇痛活性研究;鲁文雪等;《中国现代中药》;20190831;第21卷(第8期);第1049-1053页 * |
白鹃梅化学成分;张家佳等;《中国中药杂志》;20110531;第36卷(第9期);第1198-1201页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106974922A (zh) | 2017-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101012230A (zh) | 斑蝥酸钠的制备工艺 | |
JPH01157995A (ja) | 鎮痛−抗炎症活性を有するガングリオシドの内部エステル | |
EP2172206A1 (en) | The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof | |
KR20190010578A (ko) | 새로운 다파글리플로진 결정형 및 그의 제조 방법 및 용도 | |
TWI610676B (zh) | 神經細胞死抑制劑、抗阿茲海默症劑、抗腦機能減退劑、具有抗阿茲海默症作用或抗腦機能減退作用的醫藥品及神經細胞死抑制劑的製造方法 | |
CN111253247B (zh) | 一种具有抗炎活性的新酚酸类化合物的制备方法及应用 | |
CN107158050B (zh) | 圆锥绣球总香豆素苷、其制备方法及其组合物与用途 | |
WO2004039759A1 (fr) | Compose naturel servant dans le traitement de diabetes, sa preparation et son utilisation | |
CN106977560B (zh) | 2S-cardiospermin-5-benzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106977561B (zh) | Sutherlandin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
WO2024031997A1 (zh) | 一种n-n-双-恶唑烷酮生物碱类化合物、制备方法及在医药领域的应用 | |
CN106974922B (zh) | 2S-cardiospermin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974921B (zh) | 2R-cardiospermin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974923B (zh) | Sutherlandin-5-cis-p-coumarate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN106974924B (zh) | Isocardiospermin-5-p-hydroxybenzoate的制备及其在制备治疗类风湿关节炎药物中的应用 | |
CN108785316B (zh) | 香加皮c21甾类在制备ido抑制剂中的用途 | |
CN112592328B (zh) | 草豆蔻中二芳基庚烷-查尔酮聚合物及其药物组合物与应用 | |
CN110563688B (zh) | 具有抗补体活性的苯并吡喃类化合物及其用途 | |
CN101633661B (zh) | 制备斑蝥酸钠的工艺 | |
CN104447900B (zh) | 一种新化合物的制备活性与应用及质量控制 | |
CN114409544B (zh) | 具有血管舒张活性的苯丙素及其提取方法和应用 | |
CN113666895B (zh) | 卤代2-苯并[c]呋喃酮类化合物及其应用 | |
CN111825646B (zh) | 一种丁基苯肽类化合物及其制备方法和应用 | |
CN110218208B (zh) | 一种狄尔斯-阿尔德型化合物及其制备方法和应用 | |
CN110066218B (zh) | 一种含异戊二烯的溴酚化合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of 2s-cardiospermin-5-cis-p-coumarate and its application in the preparation of drugs for the treatment of rheumatoid arthritis Effective date of registration: 20211214 Granted publication date: 20201201 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20201201 Pledgee: Yantai financing guarantee Group Co.,Ltd. Pledgor: BINZHOU MEDICAL University Registration number: Y2021980014859 |